ClinicalTrials.govpublic full text
Autologous T Cell Vaccine (TCV) for Multiple Sclerosis
relapsing-remitting multiple sclerosis, phase 2b tovaxin, clinically isolated syndrome (cis), relapse-remitting multiple sclerosis (rr-ms), interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 905007
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.